Call to Schedule Free Consultation at Over 80 Centers Worldwide!

(844) GET-STEM

Stem Cell Therapy for Parkinson’s Disease: A Case Study in Quality of Life

Written by Dr. David Greene, MD, PhD, MBA on May 9, 2026

Table of Contents

When Beverly Bincey’s husband Richard began declining despite years of conventional treatment for Parkinson’s disease, she started looking beyond standard options. That search brought the couple from North Carolina to Knoxville, Tennessee, where Richard received an IV stem cell infusion at R3 Stem Cell under the care of Dr. Worthington.

Their experience — candid, measured, and now spanning two separate treatments — offers a grounded look at what stem cell therapy may offer Parkinson’s patients, and where its limits currently lie.

Why Parkinson's Patients Look Beyond Conventional Treatment

Parkinson’s disease progressively destroys dopamine-producing neurons in the brain, affecting movement, digestion, cognition, and more. Standard medications like Levodopa manage symptoms but do not slow the underlying disease. Over time, their effectiveness often becomes inconsistent.

As that gap widens, many patients and families begin exploring regenerative therapies. For the Binceys, stem cell treatment became the next step after conventional options had run their course.

Richard's History With Parkinson's

Beverly believes Richard had Parkinson’s for roughly 20 years, though he wasn’t formally diagnosed until five or six years ago. That long pre-diagnosis window is common — early Parkinson’s often presents as subtle non-motor symptoms like sleep disruption, constipation, or reduced sense of smell, long before tremor or movement changes appear.

By the time the couple sought stem cell therapy, the disease had affected Richard’s bowel function, spine, cognition, and daily engagement. “We decided to try stem cells because that was the last option we had,” Beverly said. Understanding how stem cell therapy works helped Beverly make a more confident decision.

The First Treatment and What Changed

Richard’s first infusion took place on May 25, 2015. Beverly described the results clearly:

He became more engaged and present with family and friends

His sociability returned — she described him as "outoing again"

He resumed going to the gym

His appetite improved and he gained weight

His overall quality of life meaningfully improved

These outcomes are consistent with the proposed mechanisms of mesenchymal stem cell therapy: reducing neuroinflammation, supporting surviving neurons, and improving systemic function — rather than replacing lost cells outright.

How long did the benefits last

Beverly didn’t overstate the results. The improvement lasted about six months. After that, Richard began declining again.

This tracks with early research. Studies note that while stem cell therapies show neuroprotective and symptom-modifying potential, sustained benefit likely requires repeat treatment. Duration of effect varies significantly between patients, and the field has not yet established standardized protocols for maintenance dosing. Patients curious about what to expect can review stem cell therapy outcomes and common patient questions before committing to treatment.

Returning for a Second Infusion

After Richard’s symptoms returned, the couple came back for another treatment — this time with realistic expectations. “We’re hoping to get the same results,” Beverly said.

Repeat infusion strategies are being explored in neurological research, with some evidence suggesting cumulative benefit over time. Whether Richard’s second treatment produces a similar or longer-lasting response remains to be seen, but the decision reflects a thoughtful, informed approach. Reading real patient success stories helped the family feel less alone in that process.

Why They Chose Treatment in the U.S.

Many families researching stem cell therapy encounter international clinics first. Beverly looked at those options and found them cost-prohibitive. Locating R3 Stem Cell and Dr. Worthington in Knoxville gave the family a domestic provider they could vet, afford, and trust.

For those weighing their options, R3 has published a useful comparison of U.S. vs. Mexico stem cell therapy and guidance on whether to leave the U.S. for treatment. Beverly also noted that she faced skepticism from people around her. “A lot of folks told us you’re wasting your money and your time. We said, ‘That might be the case, but we’ll find out.'” After the first treatment, she had good news to report back.

What the Research Currently Supports

Patients considering stem cell therapy for Parkinson’s disease should understand where the science stands.

Area

Current Status

Safety of IV MSC infusions

Generally well-tolerated in early human trials

Neuroprotective effects

Supported by preclinical and some early clinical data

Slowing disease progression

Not yet proven in large randomized trials

Optimal dosing and timing

Not yet standardized

FDA approval for Parkinson’s

Not approved; considered investigational

Understanding the FDA’s regulatory framework for stem cell products is important for any patient exploring this path. Stem cell therapy should complement — not replace — neurologist-supervised care. Patients should also be aware of the legal status of stem cell therapy in the United States before proceeding.

Questions to Ask Before Pursuing Treatment

Has your neurologist been consulted and are they aware of this plan?

What cell source is used, and what is the rationale?

What outcomes are realistic, and what does follow-up look like?

Is the provider transparent about both evidence and limitations?

Reputable providers will welcome these questions. R3 Stem Cell offers detailed guidance on how to choose the right stem cell clinic and how to select your treating physician — both essential readings before committing to any provider. It is also worth reviewing questions to ask before any regenerative procedure and understanding the benefits and risks of MSC therapy in advance.

A Realistic Perspective

Beverly Bincey’s account is valuable precisely because it is honest. Her husband improved. The improvement was real but time-limited. And so they returned — not with unrealistic hopes, but with the informed conviction that another window of better quality life was worth pursuing.

For Parkinson’s patients who have plateaued on conventional therapy, stem cell treatment may be a reasonable option to explore — provided expectations are grounded, medical oversight is maintained, and the provider prioritizes transparency over promises. Families can also explore financing options for stem cell therapy if cost is a barrier, and review R3’s Heroes Program for eligible patients who may qualify for additional support.

R3 Stem Cell works within that framework, offering IV stem cell infusions with physician oversight and open communication about what current evidence supports. To learn more about stem cell therapy’s potential for Parkinson’s disease, visit R3’s dedicated resource page.

Contact Us

Why Dr. Hector is "Passionate" About the Word "Natural"

Consent alone is not sufficient. Donor mothers also undergo comprehensive medical screening, which typically includes:

What Does the Bioethics Community Say?